XML 118 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Additional Information (Details)
$ in Thousands, € in Millions
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Income Taxes [Line Items]          
Tax benefits included in discontinued operations $ (1,400)   $ (11,100) $ (2,500)  
Cumulative unremitted earnings of overseas subsidiaries 797,000        
Valuation allowance 129,296   $ 271,517 $ 249,112 $ 253,649
Valuation allowance released 143,900        
Federal research and development credits 9,700        
State tax credits 31,000        
LTA 2017          
Income Taxes [Line Items]          
Notice of Assessment | €   € 2.2      
LTA 2018          
Income Taxes [Line Items]          
Notice of Assessment $ 0        
Minimum          
Income Taxes [Line Items]          
Period after loss carryforwards utilized that tax returns remain open to examination 3 years 3 years      
Maximum          
Income Taxes [Line Items]          
Period after loss carryforwards utilized that tax returns remain open to examination 4 years 4 years      
U.S. state          
Income Taxes [Line Items]          
Valuation allowance $ 27,300        
Operating loss carryforwards 43,200        
U.S. state | Rodin Therapeutics Incorporation          
Income Taxes [Line Items]          
Operating loss carryforwards 6,300        
U.S. federal          
Income Taxes [Line Items]          
Operating loss carryforwards 14,600        
U.S. federal | Rodin Therapeutics Incorporation          
Income Taxes [Line Items]          
Operating loss carryforwards 14,600        
Federal research and development credits 500        
Ireland          
Income Taxes [Line Items]          
Income taxes payable on repatriation of unremitted earnings 70,800        
Valuation allowance 102,000        
Operating loss carryforwards $ 1,300,000